The in-vivo biological activity of a drug is contingent on its ability to get to the intended site of action, commonly through a transport process that involves barrier penetration and crossing yet is ...
Due to the escalating downstream costs in the development phase, objective quality assessment of lead series long before entering clinical trials is an increasing necessity within pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback